Summary

Eligibility
for people ages 9-85 (full criteria)
Location
at UCLA
Dates
study started
study ends around
Principal Investigator
by Loren G Miller, MD, MPH (ucla)

Description

Summary

The purpose of this study is to compare how well two different antibiotics, doxycycline (DOXY) and trimethoprim/sulfamethoxazole (TMP/SMX), work at curing uncomplicated skin and soft tissue infection (uSSTI) such as 1.Boils (pus in the skin, also known as abscesses and furuncles) or 2. Infections that appear only on the skin surface (called cellulitis and erysipelas) that have pus.

Official Title

Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Treatment of Uncomplicated Skin and Soft Tissue Infections

Details

Keywords

Methicillin-resistant Staphylococcus Aureus, Skin Infection, Infections, Communicable Diseases, Soft Tissue Infections, Cellulitis, Infectious Skin Diseases, Doxycycline, Trimethoprim, Sulfamethoxazole, TMP-SMX, DOXY, Trimethoprim/sulfamethoxazole (TMP-SMX), Doxycycline (DOXY)

Eligibility

Locations

  • Olive View-UCLA Medical Center
    Sylmar California 91342 United States
  • Harbor-UCLA Medical Center
    Torrance California 90509 United States
  • Washington University
    Saint Louis Missouri 63130 United States

Lead Scientist at University of California Health

  • Loren G Miller, MD, MPH (ucla)
    HS Clinical Professor, Medicine. Authored (or co-authored) 160 research publications

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
ID
NCT03637400
Phase
Phase 2 research study
Study Type
Interventional
Participants
Expecting 462 study participants
Last Updated